subscribeSubscribe
Gyre Therapeutics Announces NMPA Approval Of Avatrombopag Maleate Tablets

Gyre Therapeutics Announces NMPA Approval Of Avatrombopag Maleate Tablets
GLOBENEWSWIRE
02 Jul 2024
Share Share
Health Canada Approves DOPTELET for Two Indications in Thrombocytopenia

Health Canada Approves DOPTELET for Two Indications in Thrombocytopenia
GLOBENEWSWIRE
06 Nov 2023
Share Share
Doptelet® (avatrombopag) receives positive opinion from CHMP ITP

Doptelet® (avatrombopag) receives positive opinion from CHMP ITP
PRNEWSWIRE
11 Dec 2020
Share Share
Swedish Orphan`s avatrombopag flunks late-stage study in chemo-induced

Swedish Orphan`s avatrombopag flunks late-stage study in chemo-induced
Douglas W. House SEEKINGALPHA
09 Oct 2020
Share Share
NICE pushes Doptelet for pre-surgery liver disease treatment

NICE pushes Doptelet for pre-surgery liver disease treatment
Anna Smith PHARMA TIMES
06 Mar 2020
Share Share
Dova Granted Orphan Drug Designation for Avatrombopag

Dova Granted Orphan Drug Designation for Avatrombopag
PR NEWSWIRE
13 Jan 2020
Share Share
Additional Analyses From Phase 3 study With Doptelet ® (avatrombopag)

Additional Analyses From Phase 3 study With Doptelet ® (avatrombopag)
PR NEWSWIRE
09 Dec 2019
Share Share
Sobi finds another fit for its dealmaking strategy

Sobi finds another fit for its dealmaking strategy
Jacob Bell BIOPHARMADIVE
01 Oct 2019
Share Share
Can Dova take on Novartis? With its 2nd Doptelet nod and a price cut, maybe so

Can Dova take on Novartis? With its 2nd Doptelet nod and a price cut, maybe so
Angus Liu FIERCE PHARMA
29 Jun 2019
Share Share
Cosmo to give Bausch Health a run for its money with FDA nod for Xifaxan rival

Cosmo to give Bausch Health a run for its money with FDA nod for Xifaxan rival
Angus Liu FIERCE PHARMA
21 Nov 2018
Share Share